These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1591991)

  • 1. Long acting diltiazem tablets.
    Drug Ther Bull; 1992 Mar; 30(5):20. PubMed ID: 1591991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the pharmacokinetic profiles of various dosage strengths of sustained-release diltiazem tablets].
    Carazzone M; Borgoglio R; Baudo A; Bertolini M; Lorenzi E
    Boll Chim Farm; 1987 Dec; 126(12):490-3. PubMed ID: 3455227
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of slow release diltiazem for essential hypertension in general practice.
    Coulter DM
    N Z Med J; 1991 Feb; 104(905):37-8. PubMed ID: 1996187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontherapeutic cyclosporine levels. Sustained-release diltiazem products are not the same.
    Cooke CE
    Transplantation; 1994 Jun; 57(11):1687. PubMed ID: 8009610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diltiazem 180 mg in delayed release formulation in mild and moderate arterial hypertension].
    Serra-Pinto L; Baptista A; Rocha E
    Rev Port Cardiol; 1995 Apr; 14(4):303-10, 283-4. PubMed ID: 7612279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily dosing of sustained-release diltiazem capsules in mild-to-moderate hypertension.
    Ginsberg D; Pappas JE; Rofman BA; Gutgsell TL; Schumer B; Karp R; Walker SD
    J Am Osteopath Assoc; 1988 Dec; 88(12):1489-92. PubMed ID: 3248953
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclosporine-sparing effects of diltiazem in renal transplantation.
    McCauley J; Ptachcinski RJ; Shapiro R
    Transplant Proc; 1989 Dec; 21(6):3955-7. PubMed ID: 2609415
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations.
    Turner SW; Jungbluth GL; Knuth DW
    Biopharm Drug Dispos; 2002 Dec; 23(9):369-77. PubMed ID: 12469330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.
    Weiss RJ; Hicks D; Bittar N; Bowers J; Shah A
    Clin Ther; 1993; 15(6):1069-75. PubMed ID: 8111804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pharmaceutical formulation for diltiazem on health care expenditures for hypertension.
    Skaer TL; Sclar DA; Robison LM; Markowski DJ; Won JK
    Clin Ther; 1993; 15(5):905-11. PubMed ID: 8269458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
    Vliegen HW; van der Wall EE; Niemeyer MG; Holwerda NJ; Bernink PJ; de Weerd P; Bosma AH; van der Wieken LR; Timmermans AJ; Molhoek GP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S55-60. PubMed ID: 1725545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release diltiazem and prevention of cardiovascular risk in hypertensive patients.
    Djian J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S20-7. PubMed ID: 1706010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of VUFB diltiazem tablets on the sick sinus and on electrophysiologic parameters of the heart atrium].
    Mádle A; Kudová J; Vainer J; Smíd J
    Vnitr Lek; 1990 Feb; 36(2):128-33. PubMed ID: 2336812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.